Menu Back to Medical-Affairs-and-Scientific-Communications-Forum

Overview

As a direct and sole result of the outbreak of the coronavirus disease (COVID-19) and due to circumstances beyond our control, DIA announced last week that it has decided to change the format of the upcoming Medical Affairs and Scientific Communications meeting from “face-to-face” (in-person) to entirely virtual.

For more information, please review the list of Frequently Asked Questions.


May 6-7: Forum

DIA’s Medical Affairs and Scientific Communications Forum is designed for medical affairs professionals, by medical affairs professionals. This forum provides a comprehensive understanding of the regulatory and compliance environment directly affecting the daily activities of medical affairs and scientific communication professionals. Made up of multiple general and breakouts sessions within three tracks covering medical communications, medical writing, and medical science liaisons, you can pick and choose which sessions to attend and create your own unique forum.

Medical Affairs professionals continue to take on more strategic leadership roles within their organizations. This year the theme for this forum is “Navigating the Future”. The program will delve into how Medical Affairs – Medical Information Professionals, Medical Writers, and Medical Science Liaisons – can best respond to the rapidly evolving landscape, and serve as a primary tactical leader in healthcare product development. Topics will cover how current technological, economic, and regulatory trends affect the vision, role, and influence of Medical Affairs.


Tracks

  1. Medical Communications Track
  2. Medical Science Liaison Track
  3. Medical Writing Track

Who should attend?

Professionals involved in:

  • Medical Communications
  • Medical Writing
  • Medical Science Liaisons
  • Medical Information
  • Medical Call Center Environment
  • Regulatory Affairs
  • Clinical Research
  • Professional Education, Training, and Development
  • Document Management/eSubmissions

Program Committee

  • Ivy Lee Chang, PharmD
    Ivy Lee Chang, PharmD Principal Medical Science Director, Medical Affairs
    Genentech, Inc., A Member of the Roche Group, United States
  • Ed  Cunningham, PharmD
    Ed Cunningham, PharmD
    Sunovion Pharmaceuticals, Inc., United States
  • Maureen  Feeney, PharmD, MBA, RPh
    Maureen Feeney, PharmD, MBA, RPh
    Takeda, United States
  • David  Meats
    David Meats Associate Director, Global Submissions, PRW
    Synchrogenix, United States
  • David  Price, PhD
    David Price, PhD Advisor, US Field Medical, Bio-Medicines Medical Sciences Liaisons
    Lilly USA, LLC, United States
  • Ann  Winter-Vann, PhD
    Ann Winter-Vann, PhD
    Whitsell Innovations, Inc., United States
  • Kevin  Appareti, MBA
    Kevin Appareti, MBA Senior Director, Global Medical Science Liaison
    Royal Philips, United States
  • J. Lynn  Bass, PharmD, RPh
    J. Lynn Bass, PharmD, RPh Senior Director, Head of Medical Science Liaisons
    Mesoblast Limited, United States
  • Dan  Benau, PhD
    Dan Benau, PhD
    University of the Sciences, United States
  • Donna  Booth, PharmD
    Donna Booth, PharmD Director, Field Medical HTA and Policy
    GlaxoSmithKline, United States
  • Dannis  Chang, PharmD
    Dannis Chang, PharmD Senior Director, Medical Communications & Operations
    Myovant Sciences, United States
  • Alex T  Eldridge (TEST)
    Alex T Eldridge (TEST)
    DIA Japan, Japan
  • Hanady  Elhadidy, PharmD
    Hanady Elhadidy, PharmD Global Medical Customer Engagement Lead
    Bristol-Myers Squibb, United States
  • Sarah  Ellinwood, PhD
    Sarah Ellinwood, PhD Associate Analyst, Medical Writer
    VERGE Scientific Communications, United States
  • Ruggero  Galici, PhD
    Ruggero Galici, PhD Associate Director, Medical Writing
    Pfizer Inc, United States
  • Jennie  Jacobson, PhD
    Jennie Jacobson, PhD
    Syneos Health, United States
  • Alexandra  Kantar, PharmD
    Alexandra Kantar, PharmD Associate Director, Global Medical Information, Specialty
    AbbVie, Inc., United States
  • Angela Benson Kodsi, PharmD
    Angela Benson Kodsi, PharmD Rare Neuroscience Medical Affairs Director
    Pfizer, Inc., United States
  • Andrea Tuttle Meyers
    Andrea Tuttle Meyers Senior Vice President, Medical Writing
    Syneos Health, United States
  • Peter  Mollegard
    Peter Mollegard Account Management Director, Medical & Patient Communications
    IQVIA, United States
  • Lori  Mouser, PharmD
    Lori Mouser, PharmD Global Head, Medical Customer Engagement
    Roche, Switzerland
  • Robert  Tamburri, PharmD, MBA
    Robert Tamburri, PharmD, MBA
    Janssen Scientific Affairs, LLC, United States
  • Amy  Van Sant, PharmD, MBA
    Amy Van Sant, PharmD, MBA President, Medical Affairs
    Ashfield Healthcare LLC, United States
  • Robin L. Winter-Sperry, DrMed, MD
    Robin L. Winter-Sperry, DrMed, MD Head, Global Field Based Medical Excellence
    Sanofi Genzyme, United States
Load More